{"id":115259,"name":"HORIZON THERAPEUTICS USA, INC. (FORMERLY HORIZON PHARMA USA, INC.)","slug":"horizon-therapeutics-usa-inc-formerly-horizon-pharma-usa-inc","state":"IL","country":"United States of America","description":"Biopharmaceutical Development","totalSpending":1600000,"filings":24,"yearlySpending":[{"year":2018,"income":290000},{"year":2019,"income":280000},{"year":2020,"income":240000},{"year":2021,"income":310000},{"year":2022,"income":240000},{"year":2023,"income":240000}],"issues":["MMM","TAX","HCR"],"firms":["COVINGTON & BURLING LLP"],"lobbyists":["JOAN KUTCHER","GARY HEIMBERG","ED MCCLELLAN","GABRIEL NEVILLE","LAYTH ELHASSANI","JOHN MINOR"],"govEntities":["HOUSE OF REPRESENTATIVES","SENATE","Labor, Dept of (DOL)"],"sampleDescriptions":["Medicare reimbursement issue; 340B reform.","Tax reform.","Tax reform.","Medicare reimbursement issue; 340B reform.","Medicare reimbursement issue; 340B reform."],"years":[2018,2019,2020,2021,2022,2023]}